Status:
COMPLETED
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Celgene Corporation
Conditions:
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to test cough, dyspnea (shortness of breath), and quality of life (QOL) questionnaires for their accuracy, sensitivity, and ability to reliably measure the severity of cou...
Detailed Description
This study in patients with IPF will determine the validity, responsiveness, and reliability of two cough measures (the Leicester Cough Questionnaire (LCQ), as well as Visual Analogue Scales (VASs) fo...
Eligibility Criteria
Inclusion
- Completion of informed consent.
- Adults over the age of 18.
- Diagnosis of IPF per ATS guidelines.
- Clinically stable at the time of enrollment defined as no antibiotics within the past month, with the exception of those patients currently listed for Lung Transplantation.
- No changes in immunosuppressive regimens (if applicable) over past month.
Exclusion
- Inability to understand or complete paper and pencil questionnaires.
- Patient not planning to return to Stanford for clinic visits.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 4 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01874223
Start Date
June 1 2013
End Date
November 4 2018
Last Update
August 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Medical Center, Chest Clinic
Stanford, California, United States, 94305-5236